Literature DB >> 17384276

14-3-3 proteins bind both filamin and alphaLbeta2 integrin in activated T cells.

Susanna M Nurmi1, Carl G Gahmberg, Susanna C Fagerholm.   

Abstract

Engagement of the T cell receptor (TCR) initiates intracellular signaling cascades that result in T cell activation, differentiation, acquisition of effector functions, or apoptosis. The signals from the TCR are coupled to distal signaling pathways by adapter proteins leading to dramatic changes in the cytoskeleton, transcription, and activation of integrins, which mediate adhesion. LFA-1 (leukocyte function-associated antigen-1) integrin (alphaLbeta2 or CD11a/CD18) plays an important role in adhesion, for example, by linking extracellular ligands to the actin cytoskeleton. The intracellular tails of integrins contain several phosphorylation sites, making them candidate-binding partners for 14-3-3 proteins, which are adaptor proteins that bind to phosphorylated ligands. In a screen for 14-3-3 binding partners in T cells, we identified both beta2 integrins and filamin. The integrin beta2 chain binds to 14-3-3 proteins through phosphorylated Thr758 after TCR ligation and this association regulates integrin-mediated cell spreading, which is necessary for adhesion. Here, we show that filamin associates with 14-3-3 proteins in activated T cells. 14-3-3 association with T cell membrane and cytoskeleton proteins after cell stimulation may mediate numerous T cell functions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17384276     DOI: 10.1196/annals.1378.035

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  8 in total

1.  Migratory activation of parasitized dendritic cells by the protozoan Toxoplasma gondii 14-3-3 protein.

Authors:  Jessica M Weidner; Sachie Kanatani; Hannes Uchtenhagen; Manuel Varas-Godoy; Tim Schulte; Klemens Engelberg; Marc-Jan Gubbels; He Song Sun; Rene E Harrison; Adnane Achour; Antonio Barragan
Journal:  Cell Microbiol       Date:  2016-05-06       Impact factor: 3.715

2.  Silencing Filamin A Inhibits the Invasion and Migration of Breast Cancer Cells by Up-regulating 14-3-3σ.

Authors:  Zhi-Min Ji; Li-Li Yang; Juan Ni; San-Peng Xu; Cheng Yang; Pei Duan; Li-Ping Lou; Qiu-Rong Ruan
Journal:  Curr Med Sci       Date:  2018-06-22

3.  14-3-3θ facilitates plasma membrane delivery and function of mechanosensitive connexin 43 hemichannels.

Authors:  Nidhi Batra; Manuel A Riquelme; Sirisha Burra; Jean X Jiang
Journal:  J Cell Sci       Date:  2013-10-25       Impact factor: 5.285

4.  Dll1 haploinsufficiency in adult mice leads to a complex phenotype affecting metabolic and immunological processes.

Authors:  Isabel Rubio-Aliaga; Gerhard K H Przemeck; Helmut Fuchs; Valérie Gailus-Durner; Thure Adler; Wolfgang Hans; Marion Horsch; Birgit Rathkolb; Jan Rozman; Anja Schrewe; Sibylle Wagner; Sabine M Hoelter; Lore Becker; Thomas Klopstock; Wolfgang Wurst; Eckhard Wolf; Martin Klingenspor; Boris T Ivandic; Dirk H Busch; Johannes Beckers; Martin Hrabé de Angelis
Journal:  PLoS One       Date:  2009-06-29       Impact factor: 3.240

5.  New insights into the phosphorylation of the threonine motif of the β1 integrin cytoplasmic domain.

Authors:  Ralph T Böttcher; Nico Strohmeyer; Jonas Aretz; Reinhard Fässler
Journal:  Life Sci Alliance       Date:  2022-01-07

6.  Differential tissue-specific protein markers of vaginal carcinoma.

Authors:  K Hellman; A A Alaiya; S Becker; M Lomnytska; K Schedvins; W Steinberg; A-C Hellström; S Andersson; U Hellman; G Auer
Journal:  Br J Cancer       Date:  2009-03-24       Impact factor: 7.640

7.  Dysregulated 14-3-3 Family in Peripheral Blood Leukocytes of Patients with Schizophrenia.

Authors:  Ying Qing; Liya Sun; Chao Yang; Jie Jiang; Xuhan Yang; Xiaowen Hu; Donghong Cui; Yifeng Xu; Lin He; Dongmei Han; Chunling Wan
Journal:  Sci Rep       Date:  2016-03-31       Impact factor: 4.379

8.  ATPR-induced G0 /G1 phase arrest in gastric cancer cells by regulating the binding of 14-3-3ε and filamin A.

Authors:  Yingli Zhao; Xing Fang; Hui Fang; Yubin Feng; Feihu Chen; Quan Xia
Journal:  Cancer Med       Date:  2018-06-04       Impact factor: 4.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.